Rego-Pérez Ignacio, Fernández-Moreno Mercedes, Fernández-López Carlos, Arenas Joaquín, Blanco Francisco J
Complejo Hospitalario Universitario Juan Canalejo, A Coruña, Spain.
Arthritis Rheum. 2008 Aug;58(8):2387-96. doi: 10.1002/art.23659.
Some studies indicate that the mitochondrion is implicated in osteoarthritis (OA). To test the hypothesis that mitochondrial DNA (mtDNA) haplogroups contribute to the prevalence and severity of knee OA, we analyzed the European mtDNA haplogroups in a Spanish population of patients with knee OA and healthy control subjects.
We combined the single-base extension assay with the polymerase chain reaction-restriction fragment length polymorphism technique to obtain the different single-nucleotide polymorphisms that characterize the European haplogroups in 457 patients with knee OA and 262 radiologic controls. Knee OA radiographs had previously been classified as grades 1-4 according to Kellgren/Lawrence (K/L) scoring system.
Individuals carrying haplogroup J showed a significantly decreased risk of knee OA (odds ratio [OR] 0.460 [95% confidence interval (95% CI) 0.282-0.748], P = 0.002). In terms of K/L scores, patients carrying haplogroup J had a less severe progression of knee OA (OR 0.351 [95% CI 0.156-0.787], P = 0.012), while those carrying haplogroup U had a more severe progression (OR 1.788 [95% CI 1.094-2.922], P = 0.025).
People carrying haplogroup J may be at a lower risk of developing knee OA, and those carrying this haplogroup in whom knee OA does not develop may have a less severe progression of the disease. Patients with knee OA carrying haplogroup U may have a more severe progression of the disease. These results indicate that mtDNA haplogroups contribute to the pathogenesis of OA.
一些研究表明线粒体与骨关节炎(OA)有关。为了验证线粒体DNA(mtDNA)单倍群影响膝关节OA患病率及严重程度这一假说,我们分析了西班牙膝关节OA患者群体及健康对照者的欧洲mtDNA单倍群。
我们将单碱基延伸分析与聚合酶链反应-限制性片段长度多态性技术相结合,以获取457例膝关节OA患者和262例放射学对照者中表征欧洲单倍群的不同单核苷酸多态性。膝关节OA的X线片先前已根据Kellgren/Lawrence(K/L)评分系统分为1-4级。
携带单倍群J的个体患膝关节OA的风险显著降低(优势比[OR]0.460[95%置信区间(95%CI)0.282-0.748],P = 0.002)。就K/L评分而言,携带单倍群J的患者膝关节OA进展较轻(OR 0.351[95%CI 0.156-0.787],P = 0.012),而携带单倍群U的患者进展更严重(OR 1.788[95%CI 1.094-2.922],P = 0.025)。
携带单倍群J的人患膝关节OA的风险可能较低,且未患膝关节OA的此类携带者疾病进展可能较轻。携带单倍群U的膝关节OA患者疾病进展可能更严重。这些结果表明mtDNA单倍群与OA的发病机制有关。